Shah, Y. D., Tobal, I., Shuaibi, S., Patel, D., Zhou, A., Mishra, M., Olet, S., Du, L. (2026). Real-world evidence of response to
                    <sup>177</sup>
                    Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) based on primary and metastatic sites in patients (pts) with neuroendocrine tumor (NET).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16317